Related Experiment Video

Updated: Aug 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Alcohol use, vascular disease, and lipid-lowering drugs

Genovefa D Kolovou1, Klelia D Salpea, Katherine K Anagnostopoulou

  • 11st Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece, and Department of Clinical Biochemistry, Vascular Disease Prevention Clinics, Royal Free Hospital, Royal Free and University College Medical School, London, UK. genkolovou@mail.gr

The Journal of Pharmacology and Experimental Therapeutics
|April 22, 2006
PubMed

Insights

Light to moderate alcohol consumption may reduce coronary heart disease (CHD) risk and total mortality. This review discusses alcohol

Area of Science:

  • Cardiology
  • Epidemiology
  • Pharmacology

Background:

  • Epidemiological and clinical studies suggest light-to-moderate alcohol (Alc) consumption is linked to reduced coronary heart disease (CHD) risk and overall mortality in middle-aged and older adults.
  • Potential cardioprotective mechanisms include improved lipid profiles, anti-clotting effects, and reduced lipoprotein (a).
  • The role of alcohol in patients undergoing lipid-lowering therapy requires careful consideration due to long-term treatment needs.

Purpose of the Study:

  • To review the beneficial effects of alcohol consumption on coronary heart disease (CHD) risk.
  • To discuss the potential side effects of alcohol consumption.
  • To evaluate the safety and suitability of alcohol consumption in patients using hypolipidemic drugs.

Main Methods:

  • This is a review article.
  • Literature search on alcohol consumption, CHD risk, and hypolipidemic drug interactions.
  • Synthesis of existing epidemiological and clinical study findings.

Main Results:

  • Light-to-moderate alcohol intake is associated with a reduced risk of coronary heart disease (CHD) and total mortality.
  • Proposed mechanisms include increased HDL cholesterol, prevention of clot formation, reduced platelet aggregation, enhanced clot dissolution, and lower lipoprotein (a).
  • Alcohol's effects may benefit patients with dyslipidemia or CHD.

Conclusions:

  • Alcohol consumption may offer cardioprotective benefits, particularly in middle-aged and elderly populations.
  • The interaction between alcohol and hypolipidemic drugs needs careful evaluation for patient safety.
  • Further research is warranted to establish definitive guidelines for alcohol consumption in patients on lipid-lowering therapy.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...